跳至主要内容
临床试验/NCT07214623
NCT07214623尚未招募不适用

i-ED COIL Use for Reduction of Chronic Subdural Hematoma Post Market Study

Kaneka Medical America LLC2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年11月30日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
200
试验地点
2
主要终点
Effectiveness

研究概览

简要总结

All participants will be asked to have a minimally invasive procedure for the treatment of chronic subdural hematoma, a blood clot on the brain. Depending on the specific condition patients may also have a surgical procedure, a mini-craniotomy or burr holes where the skull is pierced and the blood clot is drained.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pre morbid mRS 0-3
  • Chronic subdural symptomatic, requiring intervention

排除标准

  • Acute subdural hematoma
  • Intercranial mass other than subdural hematoma
  • Females pregnant or breast feeding
  • Compromised survival or inability to complete trial

结局指标

主要结局

Effectiveness

时间窗: 6 months

Incidence of hematoma recurrence or progression requiring repeat embolization within 180 days

Safety

时间窗: 90 days

Modified rankin scale at 90 days post procedure

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验